Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;18(6):1268-1279.
doi: 10.1016/j.cgh.2019.10.035. Epub 2019 Oct 30.

Positioning Therapies in the Management of Crohn's Disease

Affiliations
Review

Positioning Therapies in the Management of Crohn's Disease

Nghia H Nguyen et al. Clin Gastroenterol Hepatol. 2020 May.

Abstract

In the past decade, several new therapies with different mechanisms of action have been approved for the management of moderate to severe Crohn's disease. However, there is limited guidance on optimal positioning of agents as first- or second-line therapies because of the absence of head-to-head trials. Furthermore, given the lack of comparative studies, treatment guidelines have provided limited insight. In this review, we discuss data on key treatment attributes, comparative efficacy and safety, factors predictive of response to each agent, and propose an algorithm for positioning therapies for the management of patients with low-risk and high-risk Crohn's disease.

Keywords: Biologics; Crohn's; IBD; Therapies; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

Figures

Figure 1.
Figure 1.
Proposed algorithm for positioning therapies for patients with low-risk Crohn’s disease
Figure 2.
Figure 2.
Proposed algorithm for positioning therapies for patients with high-risk Crohn’s disease

References

    1. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2018;390:2769–2778. - PubMed
    1. Olen O, Askling J, Sachs MC, et al. Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population. Gastroenterology 2019;156:614–622. - PubMed
    1. Olen O, Askling J, Sachs MC, et al. Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964–2014. Gut 2019. - PubMed
    1. Peyrin-Biroulet L, Loftus EV Jr., Colombel JF, et al. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol 2010;105:289–97. - PubMed
    1. Frolkis AD, Dykeman J, Negron ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 2013;145:996–1006. - PubMed

Publication types